PIPr Therapeutics, Inc. — Form D

PIPr Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-23. The offering totals $10.9M, of which $10.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Donnie H McGrathDirectorNew Haven, CT
James H RosenDirectorChapel Hill, NC
Christy H ShafferDirectorChapel Hill, NC
Jonathan H SoderstromDirectorNew Haven, CT
Holden H ThorpDirectorSt. Louis, MO
James H RosenExecutive OfficerChapel Hill, NC
Clay ThorpDirectorDurham, NC
Holden ThorpDirectorDurham, NC
Heather MadsenDirectorDurham, NC
Heather MadsenExecutive OfficerDurham, NC
Bridget Ann MartellDirectorSouth San Francisco, CA
Bridget Ann MartellExecutive OfficerSouth San Francisco, CA
Holden Jonathan ThorpDirectorSt. Louis, MO
Christy Ann ShafferDirectorChapel Hill, NC
E. Jonathan SoderstromDirectorNew Haven, CT
St. John Donnie McGrathDirectorNew Haven, CT
Moncef H SlaouiDirectorKing of Prussia, PA
Marian H NakadaDirectorNew Brunswick, NJ
William WieslerDirectorDurham, NC
William WieslerExecutive OfficerDurham, NC

Other filings by this issuer (5)

FiledFormOfferingSold
2025-11-12D$2.5M$1.5M
2022-06-15D/A$18.9M$18.9M
2020-03-04D$2.0M$1.7M
2019-03-08D$5.0M$5.0M
2016-10-14D$5.0M$3.0M

More